<SEC-DOCUMENT>0001144204-19-040428.txt : 20190816
<SEC-HEADER>0001144204-19-040428.hdr.sgml : 20190816
<ACCEPTANCE-DATETIME>20190816163914
ACCESSION NUMBER:		0001144204-19-040428
CONFORMED SUBMISSION TYPE:	PRE 14C
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190816
FILED AS OF DATE:		20190816
DATE AS OF CHANGE:		20190816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MUSTANG BIO, INC.
		CENTRAL INDEX KEY:			0001680048
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473828760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14C
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38191
		FILM NUMBER:		191033896

	BUSINESS ADDRESS:	
		STREET 1:		2 GANSEVOORT STREET
		STREET 2:		9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014
		BUSINESS PHONE:		7816524507

	MAIL ADDRESS:	
		STREET 1:		2 GANSEVOORT STREET
		STREET 2:		9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14C
<SEQUENCE>1
<FILENAME>tv527752-pre14c.htm
<DESCRIPTION>PRE 14C
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
  <head>
    <title>tv527752-pre14c - none - 2.5613595s</title>
  </head>
  <body style="width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:19pt;margin-bottom:21.71pt;margin-left:27pt;width:541pt;">
        <div style="text-align:center; width:541pt; line-height:15pt;font-weight:bold;font-size:14pt;">UNITED STATES <br >SECURITIES AND EXCHANGE COMMISSION</div>
        <div style="margin-top:1pt; text-align:center; width:541pt; line-height:10pt;font-weight:bold;">Washington, D.C. 20549 </div>
        <div style="margin-top:10.48pt; text-align:center; width:541pt;">
          <div style="margin-left: 40.018%; margin-right: 40.018%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:13.99pt; text-align:center; width:541pt; line-height:15pt;font-weight:bold;font-size:14pt;">SCHEDULE 14C INFORMATION </div>
        <div style="margin-top:12pt; text-align:center; width:541pt; line-height:11pt;font-weight:bold;">Information Statement Pursuant to Section&#160;14(c) of the <br >Securities Exchange Act of 1934</div>
        <div style="margin-top:11.48pt; text-align:center; width:541pt;">
          <div style="margin-left: 40.018%; margin-right: 40.018%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.98pt; width:541pt; line-height:12pt;">Check the appropriate box: </div>
        <div style=" float:left; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9746;<br ></div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Preliminary Information Statement </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9744;<br ></div>
        <div style=" margin-top:2.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Definitive Information Statement </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9744;<br ></div>
        <div style=" margin-top:2.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14c-5(d)(2)) </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:541pt; line-height:14pt;font-weight:bold;font-size:18pt;">MUSTANG BIO, INC. <br ><font style="font-size:10pt;">(Name of Registrant As Specified In Charter) </font></div>
        <div style="margin-top:12pt; width:541pt; line-height:11pt;font-weight:bold;">Payment of Filing Fee (Check the appropriate box):</div>
        <div style=" float:left; line-height:12pt; margin-top:7.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9746;<br ></div>
        <div style=" margin-top:7.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">No fee required</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9744;<br ></div>
        <div style=" margin-top:8.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:8.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Title of each class of securities to which transaction applies:<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(2)<br ></div>
        <div style=" margin-top:10.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Aggregate number of securities to which the transaction applies<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(3)<br ></div>
        <div style=" margin-top:10.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&#160;0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(4)<br ></div>
        <div style=" margin-top:10.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Proposed maximum aggregate value of transaction: <br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(5)<br ></div>
        <div style=" margin-top:10.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Total fee paid:</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9744;<br ></div>
        <div style=" margin-top:8.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Fee paid previously with preliminary materials</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">&#9744;<br ></div>
        <div style=" margin-top:8.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Check box if any part of the fee is offset as provided by Exchange Act Rule&#160;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:8.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Amount previously paid:<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(2)<br ></div>
        <div style=" margin-top:10.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Form, Schedule or Registration Statement No.:<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(3)<br ></div>
        <div style=" margin-top:10.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Filing Party:<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:10.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(4)<br ></div>
        <div style=" margin-top:10.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">Date Filed:<br >&nbsp;&nbsp;&nbsp;</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:40pt; margin-top:2.5pt; width:501pt;">
          <div style="margin-left: 0pt; width: 501pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;min-height:660pt;margin-bottom:49.71pt;margin-left:70pt;width:456pt;">
        <div style="position:relative;z-index:-1;margin-top:6pt; text-align:center; width:456pt;">
          <img src="lg_mustangbio.jpg" alt="[MISSING IMAGE: lg_mustangbio.jpg]" height="132" width="191" >
        </div>
        <div style="margin-top:19.98pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;">THIS INFORMATION STATEMENT IS BEING PROVIDED <br >TO YOU BY THE BOARD OF DIRECTORS OF THE COMPANY</div>
        <div style="margin-top:12.48pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:13.98pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">GENERAL INFORMATION </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">This Notice and the accompanying Information Statement (&#8220;Information Statement&#8221;) are being furnished by Mustang Bio, Inc., a Delaware corporation (the &#8220;Company&#8221;) to the holders of shares of our common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;) to inform you that, on August 16, 2019, the Board of Directors of the Company (the &#8220;Board&#8221;) adopted resolutions of the Board to ratify, approve and recommend stockholder approval of an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended, to revise Article&#160;IV, Section&#160;A thereof in order to effect an increase in the authorized number of shares of the Company&#8217;s Common Stock from 50,000,000 to 85,000,000 (the &#8220;Amendment&#8221;). On August 16, 2019, the holders of a majority in voting power of issued and outstanding shares of our Common Stock and issued and outstanding shares of our Class&#160;A Preferred Stock, par value $0.0001 (together, the &#8220;Majority Holders&#8221;) approved the Amendment by written consent in lieu of a meeting (the &#8220;Written Consent&#8221;). </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The accompanying Information Statement is being furnished to our stockholders for informational purposes only, pursuant to Section&#160;14(c) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the rules and regulations prescribed thereunder. We are also furnishing the Information Statement to our stockholders in satisfaction of the notice requirement under Section&#160;228 of the DGCL. Because the Written Consent of the Majority Holders satisfies all applicable stockholder voting requirements, the Board is not soliciting your proxy or consent in connection with the matters discussed above. You are urged to read the Information Statement carefully and in its entirety for a description of the action taken by the Company and the Majority Holders. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The Amendment will not become effective before the date which is 20&#160;days after the Information Statement is first mailed to our stockholders. The Information statement is being mailed on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2019 to our stockholders of record on August 16, 2019. </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED <br >NOT TO SEND US A PROXY. </div>
        <table style="width:456pt;height:64.5pt;margin-top:13pt;border-collapse: collapse;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">Dated: &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2019 </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <div style="font-weight:bold;">By Order of the Board of Directors, </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:27pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:222pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:4.167pt 0pt 0pt 0pt; width:222pt;"></td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:222pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:222pt;">Manuel Litchman, M.D. <br >President and Chief Executive Officer</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;margin-left:70pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11pt;">
          <font style="font-weight:bold;">MUSTANG BIO, INC.</font> <br >2 Gansevoort Street, 9<font style=" position:relative; bottom:4.25pt;font-size:7.5pt;">th</font> Floor <br >New York, NY 10014 </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES <br >EXCHANGE ACT OF 1934, AS AMENDED </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">This Information Statement (the &#8220;Information Statement&#8221;) is being mailed on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2019 to the holders of record at the close of business on August 16, 2019 (the &#8220;Record Date&#8221;) of the shares of common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;) of Mustang Bio, Inc., a Delaware corporation (&#8220;Mustang&#8221;, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or the &#8220;Company&#8221;), in connection with an action taken by written consent (the &#8220;Written Consent&#8221;) of the holders of a majority in voting power of issued and outstanding shares of our Common Stock and issued and outstanding shares of our Class&#160;A Preferred Stock, par value $0.0001 (the &#8220;Preferred Stock&#8221;) (together, the &#8220;Majority Holders&#8221;) in lieu of a meeting to approve an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended (the &#8220;Certificate&#8221;), to increase the authorized number of shares of our Common Stock from 50,000,000 to 85,000,000 (the &#8220;Amendment&#8221;). </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The Majority Holders, beneficially owning 12,791,113 shares of our issued and outstanding Common Stock and 250,000 shares of our issued and outstanding Preferred Stock, have executed the Written Consent approving the Amendment. The Majority Holders held of record on the Record Date approximately 67.2% of the voting power necessary to approve the proposed Amendment. Dissenting stockholders do not have any statutory appraisal rights as a result of the action taken. The Board of Directors of the Company (the &#8220;Board&#8221;) does not intend to solicit any proxies or consents from any other stockholders in connection with this action. All necessary corporate approvals have been obtained, and this Information Statement is furnished solely to advise stockholders of the action taken by the Written Consent. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">Section&#160;228 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) generally provides that any action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a written consent thereto is signed by stockholders having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Pursuant to Section&#160;242 of the DGCL, a majority of the outstanding voting shares of stock entitled to vote thereon is required in order to amend our Certificate to effect the Amendment. In order to eliminate the costs and management time involved in obtaining proxies and to effect the above action as early as possible in order to accomplish the purposes of the Company as herein described, the Board consented to the utilization of, and successfully obtained, written consent of the Majority Holders. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">This Information Statement is being distributed pursuant to the requirements of Section&#160;14(c) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) to our stockholders of record on the Record Date. The Amendment will not become effective before the date which is 20&#160;days after this Information Statement is first mailed to our stockholders. The 20-day period is expected to conclude on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2019. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The entire cost of furnishing this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties to forward this Information Statement to the beneficial owners of the Common Stock held of record by them and will reimburse such persons for their reasonable charges and expenses in connection therewith.</div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-weight:bold;">Record Date and Vote Required </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The close of business on August 16, 2019 has been fixed as the Record Date for the determination of stockholders entitled to vote via written consent. As of such date, we had (i) 39,610,045 shares of our Common Stock outstanding and entitled to vote, (ii) 862,392 shares of our Class&#160;A common stock, par value $0.0001 per share (&#8220;Class&#160;A Common Stock&#8221;), outstanding and entitled to vote, and (iii) 250,000 shares of our Preferred Stock outstanding and entitled to vote. Each share of Common Stock and Class&#160;A Common Stock is entitled to one vote on each matter to be voted upon at a meeting or via written consent. </div>
      </div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">1</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;height:660pt;margin-left:70pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">Each share of Preferred Stock is entitled to the number of votes that is equal to one and one-tenth times a fraction, the numerator of which is the sum of&#8201; (A) the shares of outstanding Common Stock and (B) the whole shares of Common Stock into which the shares of outstanding Class&#160;A Common Stock and Preferred Stock are convertible and the denominator of which is the number of shares of outstanding Preferred Stock. As of the Record Date, there were a total of 85,200,019 votes outstanding (39,610,045 Common Stock votes plus 862,392 Class&#160;A Common Stock votes plus 44,727,582 Preferred Stock votes). </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">Pursuant to Section&#160;228 of the DGCL, unless otherwise provided in the Certificate, any corporate action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by stockholders having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all members having a right to vote thereon were present and voted. The Majority Holders, who held in the aggregate the equivalent of 57,268,695 votes, or approximately 67.2% of the voting equity of the Company, voted in favor of the Amendment by executing the Written Consent in lieu of a meeting in accordance with our By-Laws and the DGCL. The Written Consent is sufficient under the DGCL and our By-laws to approve and adopt the action described in this Information Statement. Consequently, no further stockholder action is required. </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-weight:bold;">No Dissenters&#8217; Rights </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">Under the DGCL, the Company&#8217;s stockholders are not entitled to dissenters&#8217; rights with respect to the Amendment effecting the increase in authorized shares of the Company&#8217;s Common Stock, and the Company will not independently provide stockholders with any such right. </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">
          <font style="text-transform:uppercase;">Interest of Certain Persons in Matters to be Acted Upon</font></div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">None of our directors, executive officers or any associate of a director or executive officer has a substantial interest, direct or indirect, by security holdings or otherwise, in any matter described in this Information Statement. </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The following table sets forth certain information as of August&#160;15, 2019 with respect to the holdings of: (i)&#160;each person known to us to be the beneficial owner of more than 5% of our Common Stock; (ii) each of our directors, nominees for director and named executive officers; and (iii) all directors and executive officers as a group. In accordance with applicable Securities and Exchange Commission (the &#8220;SEC&#8221;) rules, the number of shares reflected as beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC. Under those rules, beneficial ownership includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60&#160;days after August 16, 2019 through the exercise of any stock option, warrants or other rights. To the best of our knowledge, each of the persons named in the table below as beneficially owning the shares set forth therein has sole voting power and sole investment power with respect to such shares, unless otherwise indicated. Applicable&#160;percentages are based upon 39,610,045 shares of our Common Stock, 862,392 shares of our Class&#160;A Common Stock, and 250,000 shares of Class&#160;A Preferred Stock outstanding as of August&#160;15, 2019.</div>
      </div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">2</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;margin-left:70pt;width:456pt;">
        <table style="width:456pt;height:217pt;margin-top:0pt;border-collapse: collapse;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.97pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">Common Stock <br >Beneficially Owned </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Name and Address of Beneficial Owner<font style=" position:relative; bottom:3.25pt;font-size:6pt;">(1)</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Number of <br >Shares and <br >Nature of <br >Beneficial <br >Ownership </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Percentage of <br >Total Common <br >Stock </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Michael S. Weiss </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">533,158<font style="position:absolute;"><font style="font-weight:bold;font-size:14pt;"></font><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(2)</font></font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Manuel Litchman, M.D. </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">320,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.8<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Brian Achenbach </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">18,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&lt;1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Lindsay A. Rosenwald, M.D. </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">583,158<font style="position:absolute;"><font style="font-weight:bold;font-size:14pt;"></font><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(2)</font></font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Neil Herskowitz </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">84,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&lt;1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Adam J. Chill </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">76,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&lt;1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Michael J. Zelefsky </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">73,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&lt;1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">All executive officers and directors as a group </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">689,509<font style="position:absolute;"><font style="font-weight:bold;font-size:14pt;"></font><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(3)</font></font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;">5% or Greater Stockholders:</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.97pt;text-align:left;">
              <div style="white-space:nowrap;">Fortress Biotech, Inc. </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">11,870,354<font style="position:absolute;"><font style="font-weight:bold;font-size:14pt;"></font><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(4)</font></font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">30.0<font style="position:absolute;">%<font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(4)</font></font></td>
            <td style="padding:0pt;padding-left:15.955pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:14.49pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:11.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:11.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">The address of each of the directors, officers and owners of 5% or more of our common stock listed is c/o&#160;Mustang Bio, Inc., 2 Gansevoort Street, 9th Floor, New York, NY 10014. </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.97pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(2)<br ></div>
        <div style=" margin-top:9.97pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Includes 500,000 warrants issued by Fortress to each of Mr.&#160;Weiss and Dr.&#160;Rosenwald that cover shares of our common stock that are owned by Fortress. These do not represent equity compensation by us to either Mr.&#160;Weiss or Dr.&#160;Rosenwald. </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(3)<br ></div>
        <div style=" margin-top:9.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">The total calculation for all executive officers and directors as a group does not include Mr.&#160;Weiss&#8217; and Dr.&#160;Rosenwald&#8217;s warrants, which have not yet been exercised. The shares underlying the warrants are currently held by Fortress and are included in the 11,870,354 shares of common stock shown as held by Fortress. </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(4)<br ></div>
        <div style=" margin-top:9.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">Includes shares underlying 500,000 warrants issued to each of Mr.&#160;Weiss and Dr.&#160;Rosenwald.</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:82pt;margin-top:8pt;border-collapse: collapse;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">Class&#160;A Common Stock <br >Beneficially Owned </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:344.18pt;text-align:left;">
              <div style="white-space:nowrap;">Name and Address of Beneficial Owner<font style=" position:relative; bottom:3.25pt;font-size:6pt;">(1)</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Number of <br >Shares and <br >Nature of <br >Beneficial <br >Ownership </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Percentage of <br >Total Class&#160;A <br >Common Stock </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:344.18pt;text-align:left;">
              <div style="white-space:nowrap;">City of Hope </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">862,392</td>
            <td style="padding:0pt;padding-left:1.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.39pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">100.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:14.39pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:14.49pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:11.97pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:11.97pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">The address of City of Hope is 1500 East Duarte Road, Duarte, California 91010.</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:82pt;margin-top:8pt;border-collapse: collapse;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:342.86pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="text-align:center;">Class&#160;A Preferred Stock <br >Beneficially Owned </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:342.86pt;text-align:left;">
              <div style="white-space:nowrap;">Name and Address of Beneficial Owner<font style=" position:relative; bottom:3.25pt;font-size:6pt;">(1)</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Number of <br >Shares and <br >Nature of <br >Beneficial <br >Ownership </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">Percentage of <br >Total Class&#160;A <br >Preferred Stock </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.167pt 0pt; width:342.86pt;text-align:left;">
              <div style="white-space:nowrap;">Fortress Biotech, Inc. </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.805pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">250,000</td>
            <td style="padding:0pt;padding-left:1.805pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.167pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">100.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:14.49pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:11.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:11.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">The address of Fortress Biotech Inc. is c/o Fortress Biotech, Inc., 2 Gansevoort Street, 9th Floor, New&#160;York, NY 10014.</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="clear:both;font-size:0pt;">&#8203;</div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">3</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;height:660pt;margin-left:70pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11pt;font-weight:bold;">ACTION BY BOARD OF DIRECTORS AND MAJORITY HOLDERS </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION <br >TO INCREASE AUTHORIZED SHARES OF COMMON STOCK </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The Board and the Majority Holders have adopted and approved the Amendment to increase the number of our authorized shares of Common Stock from 50,000,000 to 85,000,000. The rights and privileges terms of the additional authorized shares of Common Stock will be identical to those of the currently outstanding shares of Common Stock. However, because the holders of Common Stock do not have preemptive rights to purchase or subscribe for any new issuances of Common Stock, the subsequent potential issuance of additional shares of Common Stock will reduce the current stockholders&#8217; percentage ownership interest in the total outstanding shares of Common Stock. The Amendment and the creation of additional shares of authorized Common Stock will not alter current stockholders&#8217; relative rights and limitations. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">The Certificate of Amendment of the Company&#8217;s Amended and Restated Certificate of Incorporation that reflects the increase in the authorized Common Stock is attached hereto as Appendix&#160;A. The increase in authorized Common Stock will become effective upon the filing of the Certificate of Amendment with the Secretary of State of the State of Delaware, which is expected to occur as soon as is reasonably practicable on or after the twentieth (20<font style=" position:relative; bottom:4.25pt;font-size:7.5pt;">th</font>) day following the mailing of this Information Statement to the Company&#8217;s stockholders. </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-weight:bold;">Reason for Increase in Authorized Capital </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">In order to permit us to raise capital or issue our Common Stock for other business purposes, we need to have available unissued but authorized shares of Common Stock and therefore need to increase the number of shares of our Common Stock authorized for issuance. We believe that the current number of unissued Common Stock is not sufficient to accommodate potential future issuance for proper business purposes. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">As a result of the increase in authorized Common Stock, the Company will be able to issue shares from time to time as may be required for proper business purposes, such as raising additional capital for ongoing operations, establishing strategic relationships with corporate partners, acquiring or investing in complementary businesses or products, and providing equity incentives to employees. </div>
        <div style="margin-top:12pt; width:456pt; line-height:11pt;font-weight:bold;">Effects of Increase </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">In general, the issuance of any new shares of Common Stock will cause immediate dilution to the Company&#8217;s existing stockholders, may affect the amount of any dividends paid to such stockholders and may reduce the share of the proceeds of the Company that they would receive upon liquidation of the Company. Another effect of increasing the Company&#8217;s authorized Common Stock may be to enable the Board to render it more difficult to, or discourage an attempt to, obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of present management. The Board would, unless prohibited by applicable law, have additional shares of Common Stock available to effect transactions (such as private placements) in which the number of the Company&#8217;s outstanding shares would be increased and would thereby dilute the interest of any party attempting to gain control of the Company, even if such party is offering a significant premium over the current market price of the Common Stock. Such an issuance of shares of Common Stock would increase the number of outstanding shares, thereby possibly diluting the interest of a party attempting to obtain control of the Company. The Board is not aware of any attempt, or contemplated attempt, to acquire control of the Company, and the Amendment was not presented with the intent that the increase in the Company&#8217;s authorized Common Stock be utilized as an anti-takeover measure.</div>
      </div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">4</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;height:660pt;margin-left:70pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11pt;font-weight:bold;">ADDITIONAL INFORMATION </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">We file reports with the SEC on an annual basis using Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You may read and copy any such reports and amendments thereto at the SEC&#8217;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549 on official business days during the hours of 10:00&#160;a.m. to 3:00&#160;p.m. Please call the SEC at 1-800-SEC-0330 for information on the Public Reference Room. Additionally, the SEC maintains a website that contains annual, quarterly, and current reports, proxy statements, and other information that issuers (including us) file electronically with the SEC. The SECs website address is http://www.sec.gov. You can also obtain copies of materials we file with the SEC from our Internet website found at www.mustangbio.com. Our stock is quoted on the Nasdaq Global Market under the symbol &#8220;MBIO.&#8221;</div>
      </div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">5</div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:46pt;height:660pt;margin-left:70pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:11pt;font-weight:bold;">Appendix A&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11pt;font-weight:bold;">CERTIFICATE OF AMENDMENT OF THE <br >AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF <br >MUSTANG BIO, INC. </div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">Mustang Bio, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), does hereby certify: </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(1)<br ></div>
        <div style=" margin-top:8.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">The Amended and Restated Certificate of Incorporation of the Corporation, as amended, is hereby amended by deleting the first sentence of Article&#160;IV, Section&#160;A thereof in its entirety and inserting the following in lieu thereof:</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:6pt; width:396pt; line-height:12pt;">&#8220;The total number of shares of all classes of capital stock that the Corporation shall have the authority to issue is (i)&#160;eighty-five million (85,000,000) shares of Common Stock, with $0.0001 par value, of which one million (1,000,000) shares are designated as &#8220;Class&#160;A Common Stock&#8221; (the &#8220;Class&#160;A Common Stock&#8221;) and the remainder are undesignated Common Stock, and (ii) 2,000,000 shares of Preferred Stock (the &#8220;Preferred Stock&#8221;), 250,000 of which are designated as Class&#160;A Preferred Stock (the &#8220;Class&#160;A Preferred Stock&#8221;) and the remainder are undesignated Preferred Stock.&#8221; </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.98pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">(2)<br ></div>
        <div style=" margin-top:8.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">The foregoing amendment was duly adopted in accordance with the provisions of Section&#160;242 of the General Corporation Law of the State of Delaware.</div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:6pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;">IN WITNESS WHEREOF</font>, the Corporation has caused this Certificate of Amendment of the Amended and Restated Certificate of Incorporation, as amended, to be executed and acknowledged by its duly appointed officer as of this ___ day of September, 2019. </div>
        <table style="width:456pt;height:64.5pt;margin-top:14pt;border-collapse: collapse;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:228pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">MUSTANG BIO, INC. </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:228pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:15.5pt 0pt 2.5pt 0pt; width:6pt;">By: </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:15.5pt 0pt 2.5pt 0pt; width:198pt;"></td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:228pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:198pt;">Name: Manuel Litchman, M.D. <br >Title: President and Chief Executive Officer</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="width:456pt; line-height:12pt;"></div>
      </div>
      <div style="margin-top:16pt;margin-bottom:21.71pt;margin-left:70pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:11pt;">A-1</div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_mustangbio.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_mustangbio.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M8_ULIY@'"-%8]T,W%TVZO2*>\-DI4@Y*(P.@\?LYRR*AC%9OZFO_ (#<2_\
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MW:,VQ"I(-T4P#K65, %1:,FB0=1SCL0A U:-75T5IHS4U!2U2-IZAR"4@<>
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M@-C/H[ZDD'F(V[>/_E&PYD<1L,9Z26:FL-FK",7D%FT(5%.+R363F@;PS*T
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M!&K5W1CX2U$F?N+4J8",;/\ +*_6G9^X4[($VZ*X)\5HJ62!4 Z=/>.'C(2
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MAL(;@(#K&)T@D\(V:>]+3C.+/HYFG'1[&/2_LF+-LS3] #\MJB1 GH&P!\I
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MQCJ$9*;DC&,+Z7EY5Z8YS"+A_)24@]6$QSF$>ZZ>/7;A01$1ZCJ'-^(CJ9X
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MS#=LDSRJEJL4E:KC:E43RL@]7!1<C$%A*PBFB"8)MH]FHN.R3= J2**1>DI
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M<@00#QSX9Y93$:8DE4ETDUT%$UD5DR*HK)'*HDJDH4#IJ)J$$2'3.00$! 1
M0'<-5J009'.+C!!$QE'^]?D?L? F[76ZX033<U'QP]/65%=P3W2A=M]TF9!.
MZ6_\@@Z]6F'GC]TDGZ/3E'BX^RS^\4!]/HSCC4[R'K3+K3@HU_-J@'RKKB$6
MR$1W !*94BSPW3\1 42;_M_9L6K0\K%U02/2?YO7&O=NS*<&DE1] _G]4<9G
M<Y7R8ZTVKQM!-S;AVXIN!5A*/H &>.A<N2G#^LF*?K^&MDU;*5O%0*E=/\P_
MIC7.W.J<P20D='\YCE#Q\^D5S.9!XZ?.3_O.'CA9TN;_ !E5SG4'X_MUG)0E
M D@ #HPC!4M2S-9)/3C%?/+KDE]K-GN+:*_VLKYN9"U33178]?8N4@ZHEHH4
MH],P_;J[J*%,!FJ0_+LJ<!2W%OHO$(?='<&0Y]/5],16_7?P4FBIC]\1WB/=
M'(=)]0Z<JZ,?XKR7E.3"*QO1;5='Y%$R+%KD*_D4F(J#^6I(O6Z)F<6A^/=<
M*))E^(F#6W>JV*,!QYQ+<L029'#EQ)ZHB--05=>KPJ5I;IR(2DD8\^ '7A'O
M^4W$/E9BRDP%AN6*)I"H&9FE+'+U]S'6IO .T3JHIH6D:T[DP@D$D0!;O+#[
M0QEB$[O=(8@9%]WS2[@I6;?3+D4XN3&G6L8#3.4QFJ7,C#NS.TL>QJ^P/.W"
ML;Q5@B1"M"3B=4I@$X"?(9XR$>N&\/\ 7.3>(&73U=BR+S&VV^WV]"RD_P!6
MW<2_<^F;_$=MO@;]T8LY[!B44PF^D=,:6=8<;J(J9ZCZPTR'B>ZW:5CH*G4]
MM:[!8I:442;LT20:]><0K03GZC/7$C-/4DTVA"G67#J*F0QA$-3"QW4V_;UR
M:09/NEI"/SPX%GHDA)QYRB&WVU)K]PVUYP?W=D.K6>'<+90#SFM0PY3Z8B/,
M<F<V<R,ST;BMPWA9)G.97ML=1:].G[K&RSKJ26%-S)BY2(N:CT^*9$6?/WP@
M+IK'-E'*IVY"*IA#ZEZGM]*NMJS)EM)4>S@.9.0'$D")53IJKG6-V^@3-]U8
M2.WB>0 Q)X $Q^CWP5X=XZX(<8L:\;<<?Q[6H1RCZW6Y=JDVE\AY$FS _NE\
MG!(*BRCV=EC&!!-55<S*/2;,RJ&2;I[<[7>YOWBX.5[^!6<!P2D>RD=0SYF9
MS,=-V2T4]CMK=NIL4H'>5Q6L^TH]9RY"0R$2[UK8VT-(0TA#2$-(0TA#2$-(
M0TA#2$-(0TA#2$-(1_A0ICIJ$*H=$QR&*55,$Q42,8H@"B8*IJI"<@CN'44Q
M=P]0$/37Z,#./PXB648C>8_Z:+DO"/;'>.,V;:_GB-=KOYIU3,E*L\:9'47<
MG4=.4T;$HX5QY9W:RXG54=OG->('7MT#TB8W1%#YU?B2$TE[2Y3H "1X6+4A
M@!H3)8 & $G#TQRY>?(6KH%KK+ ZW5$DJ(>[CTSB9+,T$DXDDMCHC+5-5J=K
MRYT)F,<LC%4,D"I@(LT4.41 0;OFYEF3DOIZ"FH8!#U =M6+GC%/+;6V9+$O
MY<\H^'I'Q#2$?HI_IS\F??\ XPL=U\[GW3G#^2LL8S<G,Y]RNEW[,.3639??
M=1#VT5DAN1),PCT-RI].Q.DH<W>9-+\ONIQR4@\TVO\ 5T'UH/;..NO*&M^;
MV4RT3,T[SK><_>\0#L#@D.4HJ<_4&>-,,>V=WSJPM7Q)2+Q+-VW(&OQ30W8J
MU\E%P089,320 4VT'>G2A&TF/20J,V8BQC*'D3 E?7D5YA_/TPV7=W/[XRDF
ME4HXK;2)EG'-38Q1S;F) -XT7Y]^7'X?4G>]F;_N3ZP*I"1@AU1D'L,DNG!?
M)R1F2YAE>6KJ<RL5%NW4%\L;9,S8FZAS#^*A ^4Y0^(B.VP?B :O&\V6U532
MJFIDRX!,N"0_2&2OVCD#'/ELN%P:=33TX+H)D$9^CE] S(CXT[C6_P 2!CLZ
MRK.HE*!A4C9&+ Y?0!$HMG+M%T<X .VR9%/4/3TV$:EJ#X3BDL@N-@X*P$QS
MD3,3Y193%"XX@*>4EM9&(Q,NB8$C%E6#?+7.X/Q!5,790PK<7<W360P$3<9%
MVJU9.:\T5,G -G\>O&MUS*Q,>*;(ADES%4103$1ZA,(PBML;=36KJ"I332S,
MC3QXX])QR.)BQ[=N%^AMC=+H#[S8T@A0'=&0D>0PS& '&/82GEH4M:1E$X&S
M-V*NX A RT0Q0* A\R0KMMWIRB'H8JBQOV"'QUF,;<IT#4@H5TG'^CU1KZC>
MKQ44.MNH/($)_I]<2VXY#;N244M;F-&L]'IRJ(K1ULNP,4$+*Y,<H&+ ,FCU
MU*238O4)C/#)IM#" E(H<X&*&#<'Z>W*\$J2M[BE/#K.0ZLXW5H^8O"#4):6
MU3\%+EWOL@&9'3ETDQ)W_=OG/_J2*_\ 57>M;^,M? KTB-S^#N?&GT&/(73%
MT%CJ)/.WS*=$IL24JG3(6>12A&JQTB@8R+=5^X1]RX'J  32 ZAA, %*(B #
MZLW%50O0PRXM?(8_1&/44+5(WXM4^TVWS49#UQ"5;D3Q\LUN)C&'SRPK+B;(
MJP;Y4/3)AU2H1\91)(4CN;"O6#)/%B*'!L]62-%(JE!190R0 13<FGKFV/F3
M3E4O<U#41V:NT9\HCANUJ>J/DFZH(*L/%T'0#UJTX\B>Z#B3+.7^+?&QQ@I2
MJ=AGX>4S)8G:HR:T_D66^LQ[UT\'W"[HL!'$8P#]!VHH*G\:D^./5N*AA'?4
M?JMQ7-_N(4&6QA) D?29D=DHW]%L^RTQ\5U*JATXZG#,$GCI$DF?2%=<3QAH
M.%KD:UAJ]#Q<#$,DP29Q4-'M(N-:)!Z FU8L44&J"8 'P(4 UHUK6XHK<)4L
M\29GTF).VTVR@-M)2EL9   #J PCZ9B@8!*8 ,4P"4Q3  @8!#80$!]! 0U\
MQZ10[S-1XDX*S9'7/#^/X]KR(CCR2MH)4WA8C'K)&>CG;1X-MK[,IV*MK=)/
M3*E3CBL5MU16>*G$4TU+=V-L^ZWVG^<N*U-6@B2"1-Q9'%$\D#XC.9P2#B13
MV^=W6BP57RMM;2[>1BL R;0",ERS6<]*92!FHY PZFN6F8Y7K*SD86O$.4Q1
M+#0C8X@4P^O2K-&F%2&Z1VZBF 0^(;#ZZM6FV!MUB1<0X\1\:S]"- BK*GS!
MW'43#:VF0?@0/I7K,05Y-WNY752HGM=EF)T&YIX[9%^]55:-3J!#@H=JR 2M
M&QU"E #"0A1,   ^@!J+;ZMEOMB*1% RVTE7BSTB1,O#E,YF4S*9,IF69B1;
M+NEPN:ZI=P><=4GPY:C,)GXDY#(3D)R G(3R$7S^$7C59\&PX<Q'ZTA6\C7>
M,<16*54Q,W>P>/'@@$G/BD<QDS*7I1(I4042_P#=:)3D$R3TP:H_<+S-8/P]
M8"V 9J!XJX#L^GJB\]KT[] 1<T***A0D@C@DYG\[Z.N-4%%\@65('LMKK#P-
M[9D$.XZ!,*U.'#?U_BHQ!6'$ +\ ]@ B/Q-J U.V*)W&G4II7+VAZ#C^M%E4
MN[J]J2:I*'4\_95Z1A^K$S:+SDP?;NTWF7\K1)$Y2@9*RL1/&G6$ $Y4)B).
M_:E1+N.RCHK7?;X .P#'ZG;EQ8Q;"74?5./H,CZ)Q)*7=%KJ.ZX5-+^L,/2)
MCTRB6$+/P5E8)2M=F8J>C%P 49"&D&DFR5W #?(Z9*K(F'I$!V VM(XTXRK0
MZE25C@00?08W[3K3R/$94E:#Q!!'I$?6U\1Z0TA#2$-(0TA#2$-(0TA#2$-(
M0TA#2$-(17OY1^03#CKPDSC9"336,N%OJ3W&M :^^3:3#ZQ7XR556>P1!536
M6>U:&EG,N82;]M-D)O4=BFE>R[2Y=]Q4[0054S2PXX932$H[TE<@H@(QS)B'
M[[O+=EVS5/:PFI=;+38G)14ONDIYE"25X9!,?GQJI)+IG1723624#I.DJ0JB
M9R_L.0X"4P?TAKJ2.1" <#E'-9S$U4E^M5J@I"NC;B"D<)2MA-^'6Q4 R $#
M]B7:_ITC'72M+Q&!Z/YHXW.8BM$5UJL2HS;8NX@9D(INP* ?$[)80,)A'X D
M=4=(Q%TCJ<4]X1K_ /TJ>0G*F..8.%W_ +EJK5+WC+)#*/=(@B(GO4!9*O-+
M)D, . 40#'3 JP' "@"B?3N(FVI#S;I=-51UH]]M:#^84J'[9]<=">1E831W
M"W*F/#=;< ^VE23_ &:9]D:J[O2:GDFGV?'][@(ZTTNYP4G6;37)= '$;-04
MRT58R4<\2W*847+58Q1$HE.41ZBB!@ 0JBCK*JWU;==1+4U6,K"T+3@4J29@
MCJ,7A6T5+<:1V@KFTNT;R"A:%"84E0D0>L?T1AKYF>)%QPXR2\C*_8I5_C*U
MN7K_ !U;Y:'2?N7D>4X*J5B=?M7;-%&P5X%2IJ]"1".D>AR1,O<.FGTY;/,N
MIW?3!VM"15-@!;:3)(/Q)29S"LYDD@S3.0$<J7CRMI]GU1:HE*-(Z24.*&I1
M'P*4)2*<I  $25*9,H2.^.-F((^RG8)R ;[>Y!^S,(;CMZ)-7H (EV_'X_C^
M.MJF[,GVDJ'H/Y1&E58WQ["T'KF/R&/,/<"Y"2*<A(Z-D2&*)3$;R;,"J%,4
M ,42OS,P$# 80$!]!V'\-M_87.D5F2.L'\DX\%6BN3D$GJ(_+*/JX7X?RECR
MA7+'*X.4EJK1)VO7#)$S&UAO)Q$+3XJ>8J/W]P6B$G#8]=4, )+E=]:*A#B4
M2B CK!N5QH&J58;<0BJ<2I+>.E2ED&03D2>(C+MMHKWZM!>86Y2-+2MPZ=:4
MH!$RK, <#%IF2>71JHD,5B?"]RR>_1;E*R7%_6\=TY,B90(1$9&S/DIM(42@
M'2F6*Z!*&Q3AJ&TUD<=.JJ=0TGCFI7H&'ZT3:LOW@#10T[CR@,,4MH]*C/\
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M-(1Y6\,[E(4^RL<=ST#5[R[AGR%4L-HKKRVUZ&G%$#%82$O6X^?JSR99-UA
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M;1GS/-G:8TQO7:_+6RR7J[E58QM<I-?8N9>3=0=9(9-RWA(B+;J+]2GMD52
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MR#B+$O,MT8F9<L%HM658+PLG%.VLC]/<J)$6*H"B95#= EZAWSJ"YUUL<+M
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MMQ]EREN?=5;(]1@KA"G,8AET6<Y'H/@8O2D$00DHU14S=TD.QD7"1R& #%$
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M_>17-3KRX_BQC[#O]FJ*]\T?X-J/ZQK^T3'EO U_R_*[_M2R9_VDRU[^9O\
M%*_ZAOZ#'AY4?PBC^O<^D1<R8Q2%,8Q@*4H"8QC" %*4 W$QA'8   #U'5?1
M9,92+7@Q_P"6>T>1WE(P%W+UK&%7)A?AY[4%E6<M+XQ>-+T]=0HF OY]OCXL
M"@FH!P*6\*[@0Z*9BW<Q<D[&9M-E5)+SR_&JIY@. H /V"?^B,YF*#J+6OS
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M <AMRF]0'7.[;<WTLN3!*P#P(QD>V.F770FG4^V00$%0X@X3&68,4:?IVO\
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M J\L8$6C)HFBV;I 8PCTD* ;CKG=:UN++CA*EG,DS)ZR8Z9;;;:0&VDA+8R
M  '4!@(S7?I[?_W'R&_V9U?_ %I4U\Q]Q-;S[TZLR?%G&UX?(-26RJ9FC(6O
MOS]H'AHBV56SJV*'1$X@H=!XM76+I0I=QW9%'X;CI")&^&IK:FOC_P 2_<_N
M"MW$SD-U4TW??!=.JK7B;]I\C@I3$;KR97:K?IW(9NHF8@])@TA%.G(8Y/\
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ME%FU5>*YGLC"8N:+#VY7+B 08O%$/;F=HD;]HNK?W4NQEIK_ !FU3)N.GN^
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@JCHR3T5RPRZSM&%4?@8S5(DF*92H1HYTA#2$-(1__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
